Moleculin Biotech, Inc. MBRX

I just add 4000 shares

.80 today soon

Sell this company asap

Sell it now

It’s really not difficult to estimate valuation of a company with a new anthracycline low in cardio toxicity across a whole range of indicators leading with an FDA acknowledged proof of concept AML indication. The market data is readily out there and if anything, understated because of the lifetime maximums and dose limits on current chemotherapy due to severe adverse effects. The numbers are staggering, run them yourself! The process protection patents and core patent licensed make it even more compelling. You’ve got an industry renowned medical adviser on staff to help market to his peers to boot. I continue to think they will sell and never personally conduct this protracted miracle trial and the funding/dilution is a mechanism to load up the insiders prior to that. IMO

Is there a firm date in August yet for the qrt review?

The lower the sp the higher the added shares to the insiders for significant gains upon the probable near sale

100% Vince! They may ‘plan’ the trial as stated, and issue stock and warrants to hypothetically fund but I believe their main focus is to negotiate a sale of their total portfolio now without really running the trial. AML has been the proof of concept now firmly in the bag along with patents and a whole family of potential indications for growth. The current offer I believe is really in part a tool to load up the insiders to significantly benefit from the sale so that has to be completed first. There are a ton of assets to place a very high valuation even now and I support the sale asap which could be sooner than you think.

Last day for Wally to disclose having met with FDA in 1H which has been on his corporate presentations for months. Keeping a file!

The news that pops is we’ve submitted our pivotal trial proposal to the FDA and again after FDA accepts the proposal!!!